Commonly Reported Side Effects While BPC-157 is generally well-tolerated and lacks the androgenic or hormonal side effects seen with many performance-enhancing drugs, its not entirely side-effect-free
Limited long-term and post-marketing data
A newer medication, Tirzepatide, also addresses type 2 diabetes and obesity but offers a dual-action approach by combining GLP-1 receptor agonism with GIP activation
Call your provider right away if you have: severe stomach pain (especially if it spreads to your back), gallbladder symptoms, changes in vision, a fast or irregular heartbeat, or new depression or anxiety
Patients with multiple comorbidities, such as atrial fibrillation or venous thromboembolism, are at higher risk of bleeding when using DOACs in combination with GLP-1R agonists
It is also important to rotate injection sites regularly to avoid tissue damage or irritation